Carlsbad, CANADA, Jan. 23, 2015 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSXV: ASG) announced today the first surgery in Nazareth, Israel using the EOS(TM) minimally invasive TLIF Interbody Fusion System featuring TiNano®. The surgery was performed at the Nazareth Hospital E.M.M.S by Dr. Khaled Aslan. This is the first TiNano coated interbody cage surgery performed outside the United States.
"It was great to do the first ZIP(TM) - EOS combination in Israel. The implants and instrumentation are very intuitive and easy to use, and they significantly shortened the operation time" said Dr. Khaled Aslan.
EOS is Aurora Spine's modern, minimally invasive TLIF interbody fusion cage manufactured with PEEK-Optima and precision coated with TiNano titanium plasma spray coating.
The combination of the EOS TiNano coated cage along with the ZIP ULTRA(TM) MIS fixation implant together make-up Aurora Spine's Screwless Procedure(TM). In our drive to provide the best products possible for both surgeons and patients alike, all Aurora Spine products are pre-packaged sterile.
"Aurora is changing spine surgery," said Trent J. Northcutt, Aurora's President and CEO. "We designed the ZIP(TM) MIS Interspinous Fusion System & TiNano coated interbody cages to improve spine patient outcomes, drive continued surgeon interest, and bolster our relevance as a key innovator in spine. Aurora Spine's minimally invasive Screwless Procedure is designed to provide unique benefits that deliver value to hospitals and patients around the world."
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine recently obtained its 5th FDA clearance in the past 12 months and continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company's commitment to - Simplifying the Complex.
This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company's products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.
For more information, please contact:
Aurora Spine Corporation
President and Chief Executive Officer
Chief Financial Officer
Source:Aurora Spine Corporation